IDA
ABBV icon

Intelligence Driven Advisers’s AbbVie ABBV Stock Holding History

Intelligence Driven Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$386K Buy
1,477
+278
+23% +$71.3K 0.07% 88
2026
Q2 		$302K Buy
+1,199
New +$258K 0.05% 106
2023
Q3 		– Sell
-2,879
Closed -$395K – 87
2023
Q2 		$395K Buy
+2,879
New +$422K 0.07% 62

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Intelligence Driven Advisers's ABBV Position: Q3 2026 in Review

Intelligence Driven Advisers increased its AbbVie (ABBV) stake by 23% in Q3 2026, buying an estimated $71.3K and bringing the position to 1,477 shares worth $386K. The position accounts for 0.07% of the portfolio, ranked #88.

Intelligence Driven Advisers first reported a position in ABBV in Q2 2023 and has held it in 3 quarters since. The position peaked at $395K in Q2 2023. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Intelligence Driven Advisers held 1,477 shares of AbbVie worth $386K as of Q3 2026.
  • Intelligence Driven Advisers bought 278 AbbVie shares in Q3 2026, an estimated $71.3K.
  • AbbVie made up 0.07% of Intelligence Driven Advisers's portfolio in Q3 2026, its #88 holding.
  • Intelligence Driven Advisers first reported a position in AbbVie in Q2 2023 and has held it in 3 quarters since.
  • Intelligence Driven Advisers's AbbVie position peaked at $395K in Q2 2023.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Intelligence Driven Advisers's 13F filing for Q3 2026, filed 9 Oct 2026.